Inceptus Medical

Name

Inceptus Medical

Legal name

Inceptus Medical LLC

Website

https://inceptusmedical.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Aliso Viejo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Incubator Operations: Inceptus generates returns by creating and fostering medical device companies through their incubator model, providing resources and expertise to develop companies from concept to commercialization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Inceptus Medical is a medical device company incubator that identifies promising medical device concepts, secures venture capital funding, builds management teams, and fosters companies through development and commercialization. The firm provides a combination of experienced engineering, clinical research expertise, seasoned leadership, and financial resources to nurture medical device innovations into successful companies from concept through commercialization.

Product overview

Inceptus Medical is a medical device company incubator, not a product company itself. Its portfolio includes: (1) Inari Medical, a commercial-stage company (NASDAQ: NARI) that is a leader in VTE treatment with the FlowTriever System and ClotTriever Thrombectomy System; (2) Okami Medical, a development-stage company focused on cardiovascular interventional devices, with the LOBO Vascular Occluder System (including LOBO-5, LOBO-7, and LOBO-9) that provides a single-device solution for peripheral arterial occlusion; and (3) Inceptus NewCo3, an incubation-stage company evaluating medical device opportunities. The incubator nurtures ideas from concept through commercialization, providing engineering, clinical research, leadership, and financial resources.

Differentiator

Problem solved

Functional benefit

Products and services

• Inari Medical Commercial-stage portfolio company and leader in venous thromboembolism (VTE) treatment, developing, making, and selling devices to extract large clot volumes from large vessels without the need for thrombolytic drugs. IPO'd in May 2020 on Nasdaq under ticker NARI.
• Okami Medical Development-stage portfolio company focused on the advancement of interventional devices and therapies in cardiovascular markets.
• Inceptus NewCo3 Incubation-stage portfolio company evaluating various medical device business opportunities.
• FlowTriever System Retrieval/Aspiration System for thrombectomy providing a new approach to thrombectomy without the need for thrombolytics, FDA 510(k) cleared for thrombectomy in peripheral vessels and treatment of pulmonary embolism. Recognized with 1st Place Innovation Award at the 2015 TCT Conference.
• ClotTriever Thrombectomy System Thrombectomy system used in the CLOUT Registry for extracting large clot volumes from large vessels, designed to remove clot without thrombolytics.
• LOBO Vascular Occluder System Single-device, one-and-done solution for the occlusion of a wide range of arterial targets without the need for multiple embolic devices. FDA 510(k) cleared for the occlusion of peripheral arteries, available in LOBO-5, LOBO-7, and LOBO-9 configurations.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and flagship.

• Sequent MedicalcoreTechnology or IntegrationSequent Medical licensed its proprietary MicroBraid technology to Inceptus Medical for use in select cardiovascular medical device applications. Sequent developed the WEB Aneurysm Embolization System using MicroBraid technology for neurovascular applications.
• Okami MedicalflagshipStrategic or Co-development PartnerSecond portfolio company of Inceptus, focused on advancement of interventional devices and therapies in cardiovascular markets. Inceptus founded and leads Okami Medical with $4.5M Series B financing led by USVP and board members.
• Inari MedicalflagshipStrategic or Co-development PartnerFirst portfolio company of Inceptus, commercial-stage company and leader in venous thromboembolism (VTE) treatment. IPO'd in May 2020 on Nasdaq under ticker NARI with $179.2M gross proceeds.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• InCube Labs: Medical device incubator founded by Mir Imran, focused on developing breakthrough medical devices such as Rani Therapeutics' oral drug delivery platform. Operates a similar venture creation model to Inceptus, nurturing ideas from concept through commercialization.
• Inari Medical: First portfolio company of Inceptus Medical, founded in 2013 to develop devices for venous thromboembolism treatment. Successfully IPO'd on NASDAQ in 2020 with $179.2M gross proceeds. Operates in the same cardiovascular/interventional space as Inceptus's other portfolio ventures.
• Okami Medical: Second portfolio company of Inceptus Medical, focused on cardiovascular interventional devices including the LOBO Vascular Occluder System (FDA 510(k) cleared). Development-stage company incubated by Inceptus with $4.5M Series B financing.
• The Foundry: Medical device incubator based in Menlo Park, CA, that has incubated multiple successful companies including Heartport, Evalve (acquired by Abbott), and ArthroCare. Provides a directly comparable company-creation model to Inceptus's incubation approach.

Others

• Versant Ventures: Leading healthcare venture capital firm that has co-invested in multiple Inceptus portfolio companies including Inari Medical ($4.7M Series A) and historical ventures (MicroVention, Sequent Medical). Functions as a financial partner rather than direct competitor.
• U.S. Venture Partners: Venture capital firm that has co-invested in Inceptus portfolio companies including Inari Medical and Okami Medical ($4.5M Series B). Provides financial backing for incubated ventures and serves on portfolio boards.

Broad incumbents

• Longitude Capital: Healthcare-focused venture capital firm investing across medical devices, biopharmaceuticals, and healthcare services. Operates more broadly than Inceptus but overlaps in medtech investing and company formation support.
• Catalyst Health Ventures: Early-stage healthcare and medical technology venture capital firm investing in medical devices and digital health. Operates as a more traditional VC model but overlaps with Inceptus in medtech deal flow and early-stage company support.

Regional players

• CMIC Holdings: Japanese-based CRO and medical device services company operating in healthcare R&D and commercialization. Provides analogous services in Japan to what Inceptus offers in the U.S. medical device market, serving as a regional equivalent in incubation and development support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/inceptus-medical-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inceptus Medical